Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Scott S. Billecke"'
Publikováno v:
International Journal of Yoga Therapy. 25:135-140
Background: We sought to study the feasibility of establishing a comprehensive, mostly self-directed yoga program in a hospital and its dose-effect relationship on cardiovascular risk factors and quality of life (QoL) measures over six months. Method
Autor:
Scott S. Billecke, Pamela A. Marcovitz
Publikováno v:
Vascular Health and Risk Management
The use of multiple drug regimens is increasingly recognized as a tacit requirement for the management of hypertension, a necessity fueled in part by rising rates of metabolic syndrome and diabetes. By targeting complementary pathways, combinations o
Autor:
Scott S. Billecke, Barry A. Franklin
Publikováno v:
Current Sports Medicine Reports. 11:201-208
Although considerable epidemiologic and clinical evidence suggests that structured exercise, increased lifestyle activity, or both are cardioprotective, the absolute and relative risk of cardiovascular and musculoskeletal complications appear to incr
Publikováno v:
Journal of Interventional Cardiology. 23:437-442
The clinical presentation of Takotsubo syndrome, or apical ballooning syndrome, resembles an extensive anterolateral myocardial infarction with chest pain symptoms and electrocardiographic ST-elevation or T-wave inversion noted in most patients. Howe
Autor:
Scott S. Billecke, Yoichi Osawa, Ezra R. Lowe, Yasuhiko Kamada, Anwar Y. Dunbar, Gary J. Jenkins
Publikováno v:
Molecular Pharmacology. 66:964-969
It is established that neuronal NO synthase (nNOS) is ubiquitinated and proteasomally degraded. The metabolism-based inactivation of nNOS and the inhibition of heat shock protein 90 (hsp90)-based chaperones, which are known to regulate nNOS, both lea
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 304:493-497
Nitric oxide synthase (NOS) is a highly regulated enzyme that produces nitric oxide, a critical messenger in many physiological processes. In this perspective, we explore the role of proteolytic degradation of NOS, in particular the inducible and neu
Autor:
Yasuhiko Kamada, William B. Pratt, Kimon C. Kanelakis, Scott S. Billecke, Andrew T. Bender, Patrick J. Murphy, Ezra R. Lowe, Yoichi Osawa
Publikováno v:
Journal of Biological Chemistry. 277:20504-20509
It is established that neuronal NO synthase (nNOS) is associated with the chaperone hsp90, although the functional role for this interaction has not been defined. We have discovered that inhibition of hsp90 by radicicol or geldanamycin nearly prevent
Autor:
Catherine E. Watson, Charles L. Bisgaier, Bert N. La Du, Scott S. Billecke, Dragomir I. Draganov
Publikováno v:
Pharmacogenetics. 11:123-134
Serum paraoxonase (PON1) is a high-density lipoprotein (HDL)-associated enzyme that hydrolyses aromatic esters, organophosphates and lactones and can protect low-density lipoprotein (LDL) against oxidation. These properties are influenced by a well-c
Publikováno v:
Toxicology and Applied Pharmacology. 157:227-233
Previously Haley et al. described six possible syndromes identified by factor analysis of symptoms in Gulf War veterans and demonstrated that veterans with these symptom complexes were more neurologically impaired than age-sex-education-matched well
Autor:
Robert C. Sorenson, Bert N. La Du, S. L. Primo-Parmo, Theodore J. Standiford, Scott S. Billecke, Mohamad Navab, Michael Aviram
Publikováno v:
Chemico-Biological Interactions. :379-388
In recent years several lines of evidence have indicated that serum paraoxonase (PON1), and perhaps other mammalian paraoxonases, act as important guardians against cellular damage from toxic agents, such as organophosphates, oxidized lipids in the p